What is IBI-Ag?
Established in 2017, IBI-Ag operates at the intersection of biotechnology and sustainable agriculture. The company specializes in the discovery and development of novel biological solutions designed to mitigate pest damage through selective and safe mechanisms. By utilizing advanced fermentation processes, IBI-Ag has engineered a highly cost-effective production model that allows for the widespread adoption of its bio-insect control agents. This technological edge enables agricultural producers to optimize their operations, reducing reliance on synthetic pesticides while simultaneously lowering production costs and enhancing the overall safety profile of their harvests.
How much funding has IBI-Ag raised?
IBI-Ag has raised a total of $16.1M across 2 funding rounds:
Other Financing Round
$6.1M
Series A
$10M
Other Financing Round (2025): $6.1M with participation from Corteva Agriscience and The Trendlines Group
Series A (2025): $10M led by The Trendlines Group, Corteva Agriscience, Iron Nation, and Consensus Business Group
Key Investors in IBI-Ag
Corteva Agriscience
A global leader in the agriculture business, Corteva provides advanced seed and crop protection technologies, focusing on yield optimization and sustainable farming practices.
The Trendlines Group
An investment firm that incubates and supports innovation-based agrifood and medical technologies, providing hands-on guidance from development to commercialization.
Iron Nation
An emergency impact fund dedicated to ensuring the operational continuity of early-stage Israeli startups through volunteer-driven investment and strategic support.
What's next for IBI-Ag?
With the successful closure of this Series A round, IBI-Ag is well-positioned to scale its manufacturing capabilities and expand its market reach. The strategic backing from industry leaders and impact-focused funds provides the necessary operational leverage to transition from pilot-scale development to full-scale commercial deployment. Future initiatives will likely focus on regulatory approvals in key international markets and the continued optimization of its fermentation-based production platform. As the agricultural sector faces increasing pressure to adopt sustainable practices, IBI-Ag's focus on high-efficacy, low-cost biologicals places it in a strong competitive position to capture significant market share in the global crop protection industry.
See full IBI-Ag company page
